Structural Basis for Isoprenoid Biosynthesis
类异戊二烯生物合成的结构基础
基本信息
- 批准号:6623020
- 负责人:
- 金额:$ 37.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-15 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:Bacillus subtilis Escherichia coli NAD(H) phosphate Staphylococcus aureus Streptomyces X ray crystallography alkyltransferase bacterial proteins biosynthesis enzyme activity enzyme mechanism enzyme structure flavin mononucleotide isomerase isoprenoid microorganism metabolism nucleotidyltransferase phosphates polyenes site directed mutagenesis stereochemistry structural biology
项目摘要
DESCRIPTION: (provided by applicant) The long term objective of this research
plan is to gain an understanding of the structural basis for isoprenoid
biosynthesis in bacteria and parasites, which will serve as a foundation for
the design of new classes of antibacterial and antimalarial agents. In
particular, a key aim of this proposal is to understand the structural and
mechanistic features governing the biosynthesis of the isoprenoid precursors
isopentenyl disphosphate (IPP) and the isomeric compound, dimethylallyl
diphosphate (DMAPP) catalyzed by enzymes comprising the mevalonate-independent
pathway. In addition, the structural and functional analysis of a recently
described and novel IPP isomerase that differs mechanistically and structurally
from previously described IPP isomerases will be undertaken. This type 2 IPP
isomerase, unlike the well-studied type 1 enzymes, depends on flavin
mononucleotide and NADPH for activity. Notably, this type 2 class of IPP
isomerase is found in several Gram-positive bacteria such as Staphylococcus
aureus suggesting that it will serve as an effective target for new
anti-staphylococcal drugs. Finally, the structure of the bacterial form of the
enzyme farnesyl diphosphate synthase obtained from Escherichia coli will be
determined. IPP and DMAPP are the fundamental building blocks of isoprenoids in
all organisms and are essential metabolites for the construction of numerous
higher order terpenoids. Recent independent studies demonstrated the existence
of a novel, mevalonate-independent pathway for IPP synthesis known as the
1-deoxy-D-xylulose 5-phosphate / 2-C-methyl-D-erythritol 4-phosphate (DXP/MEP)
pathway. This latter mevalonate-independent pathway utilizes pyruvate and
glyceraldehyde 3-phosphate as starting materials for production of IPP. The
DXPIMEP pathway occurs in a variety of eubacteria that includes several
pathogenic species such as Mycobacterium tuberculosis, in algae, in the
plastids of plant cells and in the apicoplast of Plasmodium falciparum the
parasite that causes malaria. Given the essential nature of the DXP/MEP pathway
in these organisms and the absence of this pathway in mammals, the enzymes
comprising the DXP/MEP pathway represent targets for the generation of
selective antibacterial and antimalarial agents. In order to better understand
the mechanistic features of this pathway and the subsequent formation of a
critical diphosphate intermediate farnesyl diphosphate (FPP), we have begun the
structural elucidation of the enzymes comprising the DXP/MEP pathway and the
formation of DMAPP and FPP from IPP isomerase and FPP synthase, respectively,
using protein x-ray crystallography.
描述:(由申请人提供)本研究的长期目标
计划是了解类异戊二烯的结构基础
生物合成的细菌和寄生虫,这将作为基础,
新型抗菌剂和抗疟剂的设计。在
特别是,这项建议的一个主要目的是了解结构和
控制类异戊二烯前体生物合成的机制特征
异戊烯基二磷酸(IPP)和异构体化合物二甲基烯丙基
二磷酸(DMAPP),其由包含甲羟戊酸非依赖性
通路此外,还对近年来出现的一种新的
描述的和新的IPP异构酶,其在机理和结构上不同
将进行从先前描述的IPP异构酶。2型IPP
异构酶,不像研究充分的1型酶,依赖于黄素
Monopoltide和NADPH的活性。值得注意的是,这种类型2类IPP
异构酶存在于几种革兰氏阳性细菌中,
金黄色葡萄球菌表明,它将作为一个有效的目标,新的
抗葡萄球菌药物最后,细菌形式的结构,
将从大肠杆菌获得的酶法呢基二磷酸合酶,
测定IPP和DMAPP是类异戊二烯的基本结构单元,
所有生物体,是构建许多生物体的必需代谢物。
高级萜类化合物。最近的独立研究表明,
一种新的,不依赖甲羟戊酸的IPP合成途径,称为
1-脱氧-D-木酮糖5-磷酸/ 2-C-甲基-D-β-4-磷酸(DXP/MEP)
通路后一种甲羟戊酸盐非依赖性途径利用丙酮酸盐,
甘油醛3-磷酸作为生产IPP的起始材料。的
DXPIMEP途径发生在多种真细菌中,包括几种
病原性物种,如结核分枝杆菌,藻类,
在恶性疟原虫的顶质体中,
引起疟疾的寄生虫鉴于DXP/MEP途径的本质,
在这些生物体中,以及在哺乳动物中缺乏这种途径,
包括DXP/MEP途径的化合物代表用于产生
选择性抗菌剂和抗疟疾剂。为了更好地理解
这一途径的机制特征和随后形成的
关键的二磷酸中间体法呢基二磷酸(FPP),我们已经开始了
包括DXP/MEP途径的酶的结构解析和
分别由IPP异构酶和FPP合酶形成DMAPP和FPP,
使用蛋白质X射线晶体学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Patrick Noel其他文献
Joseph Patrick Noel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Patrick Noel', 18)}}的其他基金
CRYSTALLOGRAPHIC ANALYSIS OF LIGNIN BIOSYNTHETIC ENZYMES
木质素生物合成酶的晶体分析
- 批准号:
7597924 - 财政年份:2007
- 资助金额:
$ 37.94万 - 项目类别:
CRYSTALLOGRAPHIC ANALYSIS OF LIGNIN BIOSYNTHETIC ENZYMES
木质素生物合成酶的晶体分析
- 批准号:
7370388 - 财政年份:2006
- 资助金额:
$ 37.94万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF MITOTIC REGULATORS
有丝分裂调节因子的结构/功能分析
- 批准号:
6180560 - 财政年份:1998
- 资助金额:
$ 37.94万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF MITOTIC REGULATORS
有丝分裂调节因子的结构/功能分析
- 批准号:
6386893 - 财政年份:1998
- 资助金额:
$ 37.94万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF MITOTIC REGULATORS
有丝分裂调节因子的结构/功能分析
- 批准号:
2910420 - 财政年份:1998
- 资助金额:
$ 37.94万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF MITOTIC REGULATORS
有丝分裂调节因子的结构/功能分析
- 批准号:
2601492 - 财政年份:1998
- 资助金额:
$ 37.94万 - 项目类别:
相似国自然基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
- 批准号:32302245
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
- 批准号:82371775
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
- 批准号:31871817
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
- 批准号:81873549
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
- 批准号:31571933
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
- 批准号:31371861
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
- 批准号:31371845
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
- 批准号:31171774
- 批准年份:2011
- 资助金额:66.0 万元
- 项目类别:面上项目
相似海外基金
Copper Sensing in Uropathogenic Escherichia coli
尿路致病性大肠杆菌中的铜感应
- 批准号:
10604449 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Knowledgebase of Escherichia coli Genome and Metabolism
大肠杆菌基因组和代谢知识库
- 批准号:
10716050 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Development of new removal method targeting Escherichia coli causing colorectal cancer
开发针对引起结直肠癌的大肠杆菌的新去除方法
- 批准号:
23K19489 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Metabolic engineering of Escherichia coli for carbon capture and hydrogen storage.
用于碳捕获和氢储存的大肠杆菌代谢工程。
- 批准号:
2869802 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Studentship
Inactivation of Escherichia coli using high hydrostatic pressure from viewpoints of cell shrinkage and expansion
从细胞收缩和扩张的角度利用高静水压灭活大肠杆菌
- 批准号:
23K05105 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural Determinants of Permeation Barriers in Escherichia coli
大肠杆菌渗透屏障的结构决定因素
- 批准号:
10749251 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
- 批准号:
10741541 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
A novel genetic switch with an optimal ON/OFF ratio to preserve growth performance prior to Escherichia coli autolysis for enhanced plasmid release
一种具有最佳开/关比的新型基因开关,可在大肠杆菌自溶之前保持生长性能,从而增强质粒释放
- 批准号:
2881246 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别:
Studentship
DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR ANTIMICROBIAL RESISTANCE ESCHERICHIA COLI
大肠杆菌耐药性体外诊断的开发
- 批准号:
10912990 - 财政年份:2023
- 资助金额:
$ 37.94万 - 项目类别: